AbCellera IPO: Shares debut at US$20 in blockbuster bid for B.C. biotech - Technology | Business in Vancouver
AbCellera: Why I Don't Love This Drug Discoverer's Business Model (NASDAQ:ABCL) | Seeking Alpha
Vancouver-based AbCellera Goes Public on Nasdaq with Massive US $555.5M IPO, Company's Market Value Triples to $15.7 Billion on 1st Day | T-Net News
AbCellera, tapped by Lilly for its COVID-19 antibody therapy, sets IPO terms with $5B valuation | Fierce Biotech
AbCellera officially closes initial public offering with $555.5 million gross proceeds | BetaKit
IPO: AbCellera Biologics
Thiel-backed therapy developer AbCellera looks to raise up to $391 million in IPO | Reuters
AbCellera IPO: Stock to Fund COVID Antibody Therapy
IPO Stock AbCellera Eyes Profitability As Covid-19 Antibody Sales Soar | Investor's Business Daily
Vancouver biotech company AbCellera's IPO nets $556M | Venture
Pre-IPO: Everything You Need To Know About AbCellera (Part I) (NASDAQ:ABCL) | Seeking Alpha
Pre-IPO: Everything You Need To Know About AbCellera (Part I) (NASDAQ:ABCL) | Seeking Alpha
IPO Stock AbCellera Eyes Profitability As Covid-19 Antibody Sales Soar | Investor's Business Daily
AbCellera Biologics's billionaire boss planning hiring spree in Vancouver hometown after record-setting IPO - : r/canada
AbCellera boosts IPO target second time in a week, seeking to raise US$483 - Technology | Business in Vancouver
424B4
IPO Alert: AbCellera Biologics (ABCL)
Wish & AbCellera Biologics Inc: Investors' Hawk-eyed On These 2 IPOs | Kalkine Media
